Genetic screening of embryos in vitro has increased yearly IVF pregnancy success rates at New Hope Fertility Center by 30 percent. By checking out this data, you can get an idea of your average chance of pregnancy success through IVF. Look: PGS/NGS is recommended because this technology is proven to increase a patient’s average chances of pregnancy success. Why does this matter? All IVF success rates vary per the context of patient and treatment protocol characteristics. Bonus: PGS/NGS identifies the gender of your embryos so that you can plan and balance the sexes of your children.
We typically recommend genetic screening in conjunction with IVF for patients meeting one or more of the following categories.
When a woman reaches an advanced maternal age – over 35 – her chances for conceiving a baby having chromosomal abnormalities increase.
There are a number of genetic conditions that can adversely alter the course of life – both for baby and parents. PGS and NGS can be performed on each embryo developing in vitro – in the lab.
PGS/NGS is used to identify the most suitable and healthiest embryo(s) to transfer. This genetic screening technology detects chromosomal deficiencies in embryos – aneuploidy – an extra or missing chromosome.
Preimplantation Genetic Screening (PGS) in vitro reduces your chances of having a baby afflicted with developmental disabilities due to chromosomal abnormalities. The vast majority of embryo implantation failures and miscarriages are due to abnormal chromosomes.
Next Generation Sequencing (NGS) is on the horizon of replacing PGS because it is a new and innovative genetic testing technology used to perform chromosomal testing in vitro.
NGS is used for comprehensive testing of embryos at a lower cost and error rate than PGS.
PGS/NGS is the observance and evaluation of the health of an embryo prior to transfer.
This genetic testing technology virtually eliminates the chance of transferring an embryo with abnormal chromosomes to the mother’s uterus. PGS/NGS analyzes the health of a single cell from a developing embryo in vitro.
This cell can identify the presence of too many or too few chromosomes making up the embryo. If an abnormal chromosome count is identified, the embryo is not transferred.
Transferring only healthy embryos significantly increases the chances of a successful IVF pregnancy and birth.
Cutting-edge embryo biopsy technology has been proven to increase IVF pregnancy success rates. This remarkable Assisted Reproductive Technology (ART) in conjunction with IVF identifies genetic and chromosomal abnormalities in embryos prior to transfer.
Only high quality embryos are transferred during a fresh IVF cycle or cryopreserved.
PGS/NGS takes place in conjunction with IVF in a controlled laboratory setting. Approximately five (5) days – blastocyst stage – after fertilization of the patient’s eggs in vitro, a single cell is removed from each of the embryos developing.
To schedule your initial consultation with PGS/NGS fertility specialist Dr. John Zhang, call 917.525.5496.